PRESS RELEASE: Microbiome Insights recognized for the fourth consecutive year in list of BC’s top emerging life sciences companies

VANCOUVER, CANADA – April 15, 2020 Microbiome Insights is honoured to be featured in the 2020 Life Science Ready to Rocket list by the management consulting firm Rocket Builders. "Ready to Rocket" is a unique business recognition list that selects technology companies with the greatest potential for growth.

The Ready to Rocket program encompasses 5 technology sectors: Information and Communications Technology, Cleantech, Life Science, Digital Health and Agri-food. Microbiome Insights was one of the 10 companies included in the Life Science Ready to Rocket List, being recognized for the fourth year in a row.

Each year, based on trend analysis, Rocket Builders identifies the top private companies best positioned to capitalize on these trends to achieve growth. This selection methodology has been an accurate predictor of business success and investment with past "Ready to Rocket" companies.

According to Rocket Builders, genomics is a critical area of innovation in the British Columbia Life Science sector with enhanced growth potential coming out of the current pandemic crisis. Founded in 2015 by leading microbiome scientists, Drs. Brett Finlay and Bill Mohn, Microbiome Insights is a global leader in microbial genetic sequencing that has worked with over 250 industry and academic clients providing the sequencing and bioinformatic analysis for more than 450 microbiome studies.    

"Each year when we choose the Ready to Rocket companies, we are looking for those companies that have achieved critical milestones along their commercialization roadmap. Microbiome Insights is an excellent example of a company taking key steps accelerating its commercial potential." said Thealzel Lee, Senior Partner, Rocket Builders.

“It is a real honor to be selected as a Ready to Rocket Life Science company again this year,” said Malcolm Kendall, Microbiome Insights’ CEO. “We are very humbled to be one of ten featured life sciences companies in British Columbia with the greatest potential for growth. Congratulations to the other leading companies on the list, we are honored to be in your company: Aspect Biosystems, Augurex Life Sciences, Clarius Mobile Health, Eupraxia Pharmaceuticals, Fusion Genomics, Life360 Innovations, Sitka Biopharmas, Vesalius Cardiovascular and Zucara Therapeutics.”


About Ready to Rocket

Ready to Rocket is a unique business recognition list that profiles technology companies with the greatest potential for growth. “Ready to Rocket” is a trademark of Rocket Builders, a respected management consulting firm servicing the technology industry.


About Microbiome Insights

Microbiome Insights, Inc. is a global leader providing end-to-end services for microbiome DNA sequencing, including state-of-the-art bioinformatic analysis. Based in Vancouver, Canada, the company's customized suite of services enables researchers and clinicians to easily and effectively include microbiome analysis in studies across a range of human, animal, agricultural, and environmental applications. The multidisciplinary team of researchers and knowledge leaders at the company's helm provide access to decades of expertise in traditional sciences such as ecology, microbiology, infectious diseases, and genetics. Microbiome Insights' award-winning team is committed to providing clients with fast, dependable, cost-effective results.



About Microbiome Insights

Microbiome Insights, Inc. is a global leader providing end-to-end microbiome sequencing and comprehensive bioinformatic analysis. The company is headquartered in Vancouver, Canada where samples from around the world are processed in its College of American Pathologist (CAP) accredited laboratory. Working with clients from pharma, biotech, nutrition, cosmetic and agriculture companies as well as with world leading academic and government research institutions, Microbiome Insights has supported over 925 microbiome studies from basic research to commercial R&D and clinical trials. The company's team of expert bioinformaticians and data scientists deliver industry leading insights including biomarker discovery, machine-learning based modelling and customized bioinformatics analysis.